Samumed, LLC Company Profile

07:41 EST 22nd November 2017 | BioPortfolio

Based in San Diego, CA, Samumed ( is a pharmaceutical platform company focused on advancing regenerative medicine and oncology applications through research and innovation. Samumed has discovered new targets and biological processes in the Wnt pathway, allowing the team to develop small molecule drugs that potentially address numerous degenerative conditions as well as many forms of cancer.

News Articles [15 Associated News Articles listed on BioPortfolio]

Samumed completes phase I chronic tendinopathy study

Samumed, a leader in musculoskeletal conditions, announced the successful completion of a phase I clinical trial in healthy subjects for its potential treatment of chronic tendinopathy, a degenerative...

Samumed’s Osteoarthritis Research Selected for an Oral Presentation at a Gordon Research Conference

Samumed, a leader in Wnt research and development, has been selected for an oral presentation at the 2017 Gordon Research Conference, “Wnt Signaling: A Pathway Implicated in Ani...

Osteoarthritis (“OA”) Patients Face Higher Costs, According to Samumed and IHS Markit

Samumed and IHS Markit Present Analysis of Medicare Claims Data for Knee OA Samumed, a leader in osteoarthritis research, and IHS Markit have jointly analyzed the healt...

Samumed reports Phase II data for SM04690 in OA

Osteoarthritis (???OA???) Patients Face Higher Costs, According To Samumed And

  Life Sciences Jobs   ...

Samumed???s Osteoarthritis Research Selected For An Oral Presentation At A Conference

  Life Sciences Jobs   ...

Samumed Successfully Completed 52-Week Phase II Study For Treatment Of Osteoarthritis Of The Knee

  Life Sciences Jobs   ...

Samumed Receives Orphan Drug Designation from FDA for SM04646 as a Treatment for Idiopathic Pulmonary Fibrosis (IPF)

Samumed announced that the U.S. Food and Drug Administration (FDA) has granted SM04646, a novel small molecule Wnt pathway inhibitor, an Orphan Drug Designation (ODD) for IPF: htt...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

An Observational, Long-term Study Evaluating the Safety, Tolerability, and Efficacy of Treatment of SM04690 or Placebo Previously Injected in the Target Knee Joint of Subjects With Moderately to Severely Symptomatic Osteoarthritis

This long-term extension study is designed to monitor the long-term safety, tolerability, and efficacy of treatment of SM04690 or placebo previously injected in the target knee joints of s...

Companies [1 Associated Companies listed on BioPortfolio]

Samumed, LLC

Based in San Diego, CA, Samumed ( is a pharmaceutical platform company focused on advancing regenerative medicine and oncology applications through research and in...

More Information about "Samumed, LLC" on BioPortfolio

We have published hundreds of Samumed, LLC news stories on BioPortfolio along with dozens of Samumed, LLC Clinical Trials and PubMed Articles about Samumed, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Samumed, LLC Companies in our database. You can also find out about relevant Samumed, LLC Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record